Literaturverzeichnis
Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK. Lymphedema
following breast-cancer treatment, including sentinel lymph node biopsy.
Lymphology 2004; 37: 73-91.
Bauernfeind I, Kühn T, im Namen der SENTINA-Studiengruppe.
Stellenwert der Sentinel-Lymph-Node-Biopsie im Rahmen neoadjuvanter
Therapiekonzepte beim Mammakarzinom: Überblick und aktuelles Studienkonzept.
Geburtsh Frauenheilk 2007; 67: 22-27.
Cabanes PA, Salmon RJ, Vilcoq JR,
Durand JC, Fourquet A, Gautier C, Asselain B. Value of axillary dissection in
addition to lumpectomy and radiotherapy in early breast cancer. The Breast
Carcinoma Collaborative Group of the Institut Curie. Lancet 1992; 339 (8804):
1245-1248.
Fisher B, Redmond C, Fisher ER,
Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R.
Ten-year results of a randomized clinical trial comparing radical mastectomy
and total mastectomy with or without radiation. N Engl J Med 1985; 312 (11):
674-681.
Fisher B, Wolmark N, Bauer M,
Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited
axillary dissection as a determinant of histologic nodal status in carcinoma of
the breast. Surg Gynecol Obstet 1981; 152 (6): 765-772.
Foster RS Jr. The biologic and
clinical significance of lymphatic metastases in breast cancer. Surg Oncol Clin
N Am 1996; 5 (1): 79-104.
Fowble B, Solin LJ, Schultz DJ,
Goodman RL. Frequency, sites of relapse, and outcome of regional node failures
following conservative surgery and radiation for early breast cancer. Int J
Radiat Oncol Biol Phys 1989; 17 (4): 703-710.
Hayward J, Caleffi M. The
significance of local control in the primary treatment of breast cancer. Lucy
Wortham James clinical research award. Arch Surg 1987; 122 (11): 1244-1247.
Kreienberg R, Kopp I, Albert U,
Bartsch HH, Beckmann MW, Berg D, Bick U, du Bois A, Budach W, Dunst J, Engel B,
Ernst M, Geraedts M, Henscher U, Hölzel D, Jackisch C, König K, Kreipe H, Kühn
T, Lebeau A, Leinung S, Link H-J, Lück H, Madjar H, Maiwald A, Maiwald G,
Marschner N, Marx M, von Minckwitz G, Naß-Griegoleit I, Possinger K, Reiter A,
Sauerbrei W, Schlake W, Schmutzler R, Schreer I, Schulte H, Schulz K-D, Souchon
R, Thomssen C, Untch M, Wagner U, Weis J, Zemmler T. Interdisziplinäre
S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms.
Deutsche Krebsgesellschaft e.V., Informationszentrum für Standards in der
Onkologie (ISTO) (Hrsg.). Berlin. 2008.
Kuehn T, Bembenek A, Decker T, Munz DL, Sautter-Bihl ML,
Untch M, Wallwiener D. A concept for the clinical implementation of sentinel
lymph node biopsy in patients with breast carcinoma with special regard to
quality assurance. Cancer 2005; 103: 451-461.
Kuehn T, Bembenek A, Büchels H, Decker T, Dunst J,
Müllerleile U, Munz DL, Ostertag H, Sautter-Bihl ML, Schirrmeister H, Tulusan
AH, Untch M, Winzer KJ, Wittekind C. Sentinel-Node Biopsie beim Mammakarzinom:
Interdisziplinär abgestimmter Konsensus der Deutschen Gesellschaft für Senologie
für eine qualitätsgesicherte Anwendung in der klinischen Routine. Onkologe
2003; 9: 1011-1016.
Peintiger F, Reitsamer R, Stranz H, Ralph G. Comparison of
quality of life and arm complaints after axillary lymph node dissection versus
sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003; 89:
648-652.
Petrek JA, Blackwood MM. Axillary
dissection: current practice and technique. Curr Probl Surg 1995; 32 (4):
257-323.
Reitsamer R, Peintiger F, Rettenbacher L, Prokop E. Sentinel
node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg
Oncol 2003; 84: 63-67.
Veronesi U, Rilke F, Luini A,
Sacchini V, Galimberti V, Campa T, Dei BE, Greco M, Magni A, Merson M.
Distribution of axillary node metastases by level of invasion. An analysis of
539 cases. Cancer 1987; 59 (4): 682-687.
Stand 31.03.2008
